Wenyan Ren

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Inflammatory Response

Acute Respiratory Distress Syndrome

Roux En Y Gastric Bypass

Top Venues

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Zhenfei Bi, Weiqi Hong, Haiying Que, Cai He, Wenyan Ren, Jingyun Yang, Tianqi Lu, Li Chen, Shuai-Yao Lu, Xiao-Zhong Peng, Yanping Qian
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice. Signal transduction and targeted therapy 6 (1) (2021)